Yirui Biosciences: The controlling shareholder and its concerted actions collectively reduced their holdings by 3.3 million shares, accounting for 0.8147% of the total share capital.

Eire Bio announced that the company's controlling shareholder, Eire Venture Capital, and its concerted actors, Yidari, Yikairi, collectively reduced their holdings in the company by 3.3 million shares through block trades, accounting for 0.8147% of the total share capital of the company. After this equity change, the proportion of company shares held by the controlling shareholder Eire Venture Capital, the actual controller Zhu Hai, and their concerted actors decreased from 57.7992% to 56.9845%, reaching a multiple of 1% change.